Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2025

Mar 8, 2025

34576_dirs_2025-03-07_9b401346-94cd-48b8-80d6-8acd9517e6ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2025-03-06

Reporting Person: Wettig Thane (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-06 Common Stock F 22038 $0.39 Disposed 397915 Direct
2025-03-06 Common Stock A 781 Acquired 398696 Direct
2025-03-06 Common Stock F 367 $0.39 Disposed 398329 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1000 Indirect

Footnotes

F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.

F2: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025.

F3: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant.